Inclusion Body Myositis clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • ABC008 for Inclusion Body Myositis

    open to eligible people ages 40 years and up

    A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis

    San Francisco, California and other locations

Our lead scientists for Inclusion Body Myositis research studies include .

Last updated: